For a 2‑month‑old infant weighing 3.5 kg, what dose of intravenous paracetamol (acetaminophen) should be administered?

Dosing Recommendation for IV Paracetamol in a 2-Month-Old, 3.5 kg Infant

For a 2-month-old infant weighing 3.5 kg, administer intravenous paracetamol at 12.5 mg/kg every 6 hours (approximately 44 mg per dose), which translates to a total daily dose of 50 mg/kg or 175 mg per day.

Rationale and Evidence Base

The dosing recommendation is derived from pharmacokinetic studies specifically conducted in neonates and young infants. Weight is the primary determinant of paracetamol clearance in this age group, accounting for 57.5% of clearance variance 1. Postmenstrual age contributes minimally (only 2.2% of variance) to clearance differences 1.

Age-Specific Dosing Framework

For neonates and infants, the evidence supports the following approach:

• Term neonates (≥37 weeks postmenstrual age) to 2 months: 12.5 mg/kg every 6 hours 2, 3
• This dosing achieves target mean steady-state concentrations of 9-11 mg/L, which is therapeutic for pain management 4
• Loading dose considerations: A 20 mg/kg loading dose followed by 10 mg/kg every 6 hours can be used for neonates 32-44 weeks postmenstrual age 4, though the maintenance dose of 12.5 mg/kg is also well-supported

Critical Safety Considerations

This infant's weight of 3.5 kg at 2 months is concerning and suggests failure to thrive or prematurity. Normal 2-month-old infants typically weigh 4.5-6 kg. You must determine:

1. Actual postmenstrual age: If this infant was premature, adjust dosing based on postmenstrual age rather than chronological age
2. Hepatic function: Low weight may indicate underlying conditions affecting drug metabolism
3. Concurrent medications: Assess for drugs that may affect paracetamol metabolism

Dosing Adjustments for Special Circumstances

If the infant is <32 weeks postmenstrual age (which would be unusual at 2 months chronological age but possible with extreme prematurity):

• Use 12 mg/kg loading dose, then 6 mg/kg every 6 hours 4
• Total daily dose: 24 mg/kg/day

If hepatic dysfunction or elevated unconjugated bilirubin is present:

• Reduce dose by 25-30% as these factors decrease clearance 1
• Monitor more closely for adverse effects

Administration Details

• Infusion time: Administer over 15 minutes 2
• Maximum concentration: Use appropriate dilution (typically 10 mg/mL)
• Monitoring: Track for hypotension (rare but reported), hepatotoxicity with prolonged use, and therapeutic efficacy

Common Pitfalls to Avoid

1. Do not use adult or older pediatric dosing: The 15 mg/kg every 6 hours dose used in older infants (>2 years) will result in supratherapeutic levels in neonates 1
2. Do not exceed 50 mg/kg/day total dose in this age group without specialist consultation
3. Avoid assuming normal pharmacokinetics: This underweight infant may have altered drug handling
4. Do not use rectal or oral formulations interchangeably: IV dosing differs significantly from other routes

Duration and Monitoring

• Limit duration: Safety data beyond 48-72 hours in neonates is limited 3
• Hepatic monitoring: If treatment extends beyond 48 hours, check liver function tests
• Reassess need: Continuously evaluate whether IV route remains necessary or if transition to enteral route is possible

The recommended dose of 12.5 mg/kg (44 mg) every 6 hours provides effective analgesia while maintaining safety margins in this vulnerable population 2, 3, 1.